Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease

This study has been terminated.
(Due to a safety signal found at a planned interim safety review, further conduct of this safety study is not recommended hence the study was terminated.)
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: August 25, 2011
Last updated: April 9, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 29, 2014